Effects of abatacept for those at high risk of rheumatoid arthritis

Steffen U, Tascilar K, Santopietro M, Feuchtenberger M, Schett G, Rech J (2026)

Publication Type: Journal article

Publication year: 2026

Journal

The Lancet Rheumatology Elsevier

Book Volume: 8

Pages Range: e326-e328

Journal Issue: 5

DOI: 10.1016/S2665-9913(26)00052-4

Authors with CRIS profile

Ulrike Steffen Department of Medicine 3 – Rheumatology and Immunology Koray Tascilar Department of Medicine 3 – Rheumatology and Immunology Milena Santopietro Lehrstuhl für Innere Medizin III Georg Schett Lehrstuhl für Innere Medizin III Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology

Involved external institutions

MED | Bayern Ost

Germany (DE)

How to cite

APA:

Steffen, U., Tascilar, K., Santopietro, M., Feuchtenberger, M., Schett, G., & Rech, J. (2026). Effects of abatacept for those at high risk of rheumatoid arthritis. The Lancet Rheumatology, 8(5), e326-e328. https://doi.org/10.1016/S2665-9913(26)00052-4

MLA:

Steffen, Ulrike, et al. "Effects of abatacept for those at high risk of rheumatoid arthritis." The Lancet Rheumatology 8.5 (2026): e326-e328.

BibTeX: Download